Stryker unveiled its updated Mako surgical robot and orthopedic companies expect procedure volumes to remain steady despite ...

Stryker Co. (NYSE:SYK – Get Free Report) has earned a consensus recommendation of “Moderate Buy” from the twenty ratings ...

Stryker has introduced the latest version of its Mako SmartRobotics system, enhancing precision in orthopedic surgeries. The ...

SYK unveils next-gen Mako SmartRobotics, revolutionizing hip, knee and spine surgeries with greater precision and first-to-market robotic hip revision technology.

Stryker has unveiled its latest Mako SmartRobotics™ innovations at the AAOS 2025 Annual Meeting. The company introduced Mako ...

Medtech company Stryker showcased new advancements across its Mako SmartRobotics portfolio at the American Academy of Orthopaedic Surgeons’ 2025 Annual Meeting in San Diego over March 10-14. Mako ...

Those include augment and screw planning, intraoperative screw trajectory guidance and compatibility with Stryker’s revision ...

Alphatec Holdings continues to benefit from M&A-related disruptions at key competitors. Read why I reiterate Buy rating for ...

Stryker (NYSE:SYK – Get Free Report) was downgraded by equities research analysts at StockNews.com from a “buy” rating to a ...

Valued at a market cap of $148.8 billion, Stryker Corporation (SYK) is a medical device company that operates in the ...

Ever-expanding applications of robotic surgery platforms allow health care providers to leverage the technology to reduce ...

The data points provided are only related to the company's focus related to Spine Surgery Devices markets. Leading global Spine Surgery Devices market players and manufacturers are studied to give ...